Journal Home
Search for

Volume 65, Issue 3, Pages 218-222 (March 2010)


View previous. 8 of 18 View next.

Criteria for the safe avoidance of needle sampling in young women with solid breast masses

A.J. MaxwellCorresponding Author Informationemail address, J.M. Pearson

Received 23 August 2009; received in revised form 12 November 2009; accepted 25 November 2009.

Aim

To establish clinical and ultrasonic criteria by which needle sampling can be safely avoided in young women with solid breast masses.

Materials and methods

The databases of a large hospital were searched for breast cancers, phyllodes tumours, and papillomas diagnosed in women below the age of 30 years. In addition, the clinical and sonographic findings in female patients less than 25 years of age presenting with a solid breast mass over a 1-year period were reviewed.

Results

Nine women with breast cancer, seven with phyllodes, and six with papillomas were found. No delayed diagnoses in those who had ultrasound would have been made if the following criteria had been applied to avoid needle sampling: age less than 25 years; no known risk factors for breast malignancy; mass not rapidly enlarging; smooth discrete mobile mass on clinical examination, or lesion impalpable; well-defined homogeneously isoechoic or mildly hypoechoic solid mass; less than 3cm in greatest dimension; ovoid shape, aligned parallel to the skin surface; smooth or gently lobulated contour (two or three lobulations only; no microlobulation); thin echogenic pseudocapsule; no calcification; no acoustic shadowing. Needle sampling could have been safely avoided in approximately two-thirds of the women reviewed below the age of 25 with a solid breast mass.

Conclusion

Application of the proposed criteria would spare a significant number of young women unnecessary needle sampling.

Bolton Breast Unit, Royal Bolton Hospital, Bolton BL4 0JR, UK

Corresponding Author InformationGuarantor and correspondent: A.J. Maxwell, Bolton Breast Unit, Royal Bolton Hospital, Bolton BL4 0JR, UK. Tel.: +44 1204 390046; fax: +44 1204 390385.

PII: S0009-9260(09)00420-6

doi:10.1016/j.crad.2009.11.009


View previous. 8 of 18 View next.